ArticleEpigenetics2016

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.

Sebastian Meller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.